
Ziverdo Kit
- Active Ingredient:
Ivermectin/Doxycycline/Zinc acetate
- Indication:
bacterial and parasitic infections,
- Manufacturer:
Shreya-Menarini-Zuventus
- Packaging:
33 pills in kit
- Delivery Time:
6 To 15 days

Ivermectin/Doxycycline/Zinc acetate
bacterial and parasitic infections,
Shreya-Menarini-Zuventus
33 pills in kit
6 To 15 days
| |||||||||||||||||||||||||||
Ziverdo Kit consists of three main components zinc acetate, doxycycline, and ivermectin. It is primarily designed to tackle various health challenges, particularly infections. The medicine has gained widespread traction during COVID-19 as a part of off-label treatment.
Furthermore, the kit continues to be used for traditional applications, to address bacterial and parasitic infections, and as a general immune booster.
The Ziverdo Kit introduction has been widely linked to the potential role in combating secondary infection and also immune supportive properties.
The Ziverdo Kit has also received varied responses both from government and healthcare regulators as well and especially during its initial promotions. At the time of the pandemic, many governments in low and also middle countries in Asia and Africa promoted Ziverdo Kit as a part of early treatment protocol.
Moreover, the kit was valued for its affordability and even accessibility and especially in resource-constrained settings. The Indian health authorities later revised treatment protocols to align with the WHO recommendations for ivermectin and doxycycline for COVID-19 treatment.
The kit does offer a multi-pronged approach to health, targeting bacteria, parasites, and immune deficiencies. No doubt, Ziverdo Kit supports overall health and beyond immediate illness management.
The Ziverdo Kit is a versatile health supplement and, in turn, valued for its efficacy in managing both infections and boosting immunity.
In African countries, like Nigeria the use of Ziverdo Kit was promoted in public health campaigns and given its potential utility in treating parasitic infections, together with speculative COVID-19 benefits.
Reviews
There are no reviews yet.